Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In the modern era, cardiologists managing patients and families with cardiomyopathies need to be familiar with every stage of the diagnostic pathway from clinical phenotyping to the prescription and interpretation of genetic tests. This clinical consensus statement from the ESC Council for Cardiovascular Genomics aims to promote the integration of genetic testing into routine cardiac care of patients with cardiomyopathies, as recommended in the 2023 ESC guidelines for cardiomyopathies. The document describes the types of genetic tests currently available and provides advice on their prescription and for counselling after the return of genetic findings, including the approach in patients and families with variants of unknown significance.

Original publication

DOI

10.1093/eurheartj/ehae747

Type

Journal

European heart journal

Publication Date

01/2025

Volume

46

Pages

344 - 353

Addresses

Department of Inherited Cardiovascular Conditions, Barts Heart Centre, St Bartholomew's Hospital, London, UK.

Keywords

Humans, Cardiomyopathies, Consensus, Genetic Counseling, Genomics, Genetic Testing